520A — J-Pharma Co Share Price
0.000.00%
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.89 | ||
| Price to Tang. Book | 4.89 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -66.68% | ||
| Return on Equity | -90.99% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
J-Pharma Co Ltd is a Japan-based company engaged primarily in pharmaceutical research and development, grounded in drug discovery targeting solute carrier (SLC) transporters. The Company operates the research-driven drug discovery business segment. The Company focuses on the L-type amino acid transporter 1 (LAT1), originally identified by its founders, and promotes the development of LAT1 inhibitors that address the unmet medical needs of patients with cancers and autoimmune diseases who have limited treatment options. The Company’s clinical development pipeline consists of Nanvuranlat (JPH203) and JPH034.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- December 26th, 2005
- Public Since
- March 25th, 2026
- No. of Employees
- 16
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 17,983,145
- Address
- Leading Venture Plaza 1, MINATO-KU, 105-0013
- Web
- https://www.j-pharma.com
- Phone
- +81 364324270
- Auditors
- Ginga Audit Corporation
Upcoming Events for 520A
Similar to 520A
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the J-Pharma Co share price?
As of Today at 21:29 UTC, shares in J-Pharma Co are trading at ¥637. This share price information is delayed by 15 minutes.
How has the J-Pharma Co share price performed this year?
Shares in J-Pharma Co last closed at ¥637 and the price had moved by over the past 365 days. In terms of relative price strength the J-Pharma Co share price has matched the Nikkei 225 Index by over the past year.
What are the analyst and broker recommendations for J-Pharma Co?
There is no consensus recommendation for this security.
Find out moreWhat is the J-Pharma Co dividend yield?
J-Pharma Co does not currently pay a dividend.
Does J-Pharma Co pay a dividend?
J-Pharma Co does not currently pay a dividend.
When does J-Pharma Co next pay dividends?
J-Pharma Co does not currently pay a dividend.
How do I buy J-Pharma Co shares?
To buy shares in J-Pharma Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of J-Pharma Co?
As of the previous close price of ¥637, shares in J-Pharma Co had a market capitalisation of ¥11bn.
Where are J-Pharma Co shares listed?
Here are the trading details for J-Pharma Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 520A
What kind of share is J-Pharma Co?
Based on an overall assessment of its quality, value and momentum J-Pharma Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a J-Pharma Co share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the J-Pharma Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like J-Pharma Co. Over the past six months, its share price has matched the Nikkei 225 Index by .
As of the last closing price of ¥637, shares in J-Pharma Co were trading -6.23% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the J-Pharma Co PE Ratio?
The J-Pharma Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥637.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of J-Pharma Co?
We do not have data on J-Pharma Co's directors